Revenue reached $14.45 billion, up 5% year-over-year, as oncology and other recently launched products offset steep declines ...

Pfizer has today posted better than expected quarterly earnings and said a recent favourable European court ruling on its ...

Operational revenue from Pfizer’s Covid vaccine Comirnaty and Paxlovid pill to treat the illness declined 59% and 63%, ...

A legal settlement has put wind behind Pfizer’s sales into 2029—at which point key obesity moves will take the helm.

Is Pfizer a yield trap? No way.